New agents in the Treatment of Myeloma Bone Disease

Patients with multiple myeloma develop a devastating bone disease driven by the uncoupling of bone remodelling, excess osteoclastic bone resorption and diminished osteoblastic bone formation. The bone phenotype is typified by focal osteolytic lesions leading to pathological fractures, hypercalcaemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Ring, Elizabeth S., Lawson, Michelle A., Snowden, John A., Jolley, Ingrid, Chantry, Andrew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805798/
https://www.ncbi.nlm.nih.gov/pubmed/29098361
http://dx.doi.org/10.1007/s00223-017-0351-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805798/
https://www.ncbi.nlm.nih.gov/pubmed/29098361
http://dx.doi.org/10.1007/s00223-017-0351-7

Ejemplares similares